Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 152

1.

ICTV Virus Taxonomy Profile: Arenaviridae.

Radoshitzky SR, Buchmeier MJ, Charrel RN, Clegg JCS, Gonzalez JJ, Günther S, Hepojoki J, Kuhn JH, Lukashevich IS, Romanowski V, Salvato MS, Sironi M, Stenglein MD, de la Torre JC, ICTV Report Consortium.

J Gen Virol. 2019 Aug;100(8):1200-1201. doi: 10.1099/jgv.0.001280. Epub 2019 Jun 13.

PMID:
31192784
2.

Novel DNA-launched Venezuelan equine encephalitis virus vaccine with rearranged genome.

Tretyakova I, Tibbens A, Jokinen JD, Johnson DM, Lukashevich IS, Pushko P.

Vaccine. 2019 May 31;37(25):3317-3325. doi: 10.1016/j.vaccine.2019.04.072. Epub 2019 May 6.

PMID:
31072736
3.

Taxonomy of the order Bunyavirales: update 2019.

Abudurexiti A, Adkins S, Alioto D, Alkhovsky SV, Avšič-Županc T, Ballinger MJ, Bente DA, Beer M, Bergeron É, Blair CD, Briese T, Buchmeier MJ, Burt FJ, Calisher CH, Cháng C, Charrel RN, Choi IR, Clegg JCS, de la Torre JC, de Lamballerie X, Dèng F, Di Serio F, Digiaro M, Drebot MA, Duàn X, Ebihara H, Elbeaino T, Ergünay K, Fulhorst CF, Garrison AR, Gāo GF, Gonzalez JJ, Groschup MH, Günther S, Haenni AL, Hall RA, Hepojoki J, Hewson R, Hú Z, Hughes HR, Jonson MG, Junglen S, Klempa B, Klingström J, Kòu C, Laenen L, Lambert AJ, Langevin SA, Liu D, Lukashevich IS, Luò T, Lǚ C, Maes P, de Souza WM, Marklewitz M, Martelli GP, Matsuno K, Mielke-Ehret N, Minutolo M, Mirazimi A, Moming A, Mühlbach HP, Naidu R, Navarro B, Nunes MRT, Palacios G, Papa A, Pauvolid-Corrêa A, Pawęska JT, Qiáo J, Radoshitzky SR, Resende RO, Romanowski V, Sall AA, Salvato MS, Sasaya T, Shěn S, Shí X, Shirako Y, Simmonds P, Sironi M, Song JW, Spengler JR, Stenglein MD, Sū Z, Sūn S, Táng S, Turina M, Wáng B, Wáng C, Wáng H, Wáng J, Wèi T, Whitfield AE, Zerbini FM, Zhāng J, Zhāng L, Zhāng Y, Zhang YZ, Zhāng Y, Zhou X, Zhū L, Kuhn JH.

Arch Virol. 2019 Jul;164(7):1949-1965. doi: 10.1007/s00705-019-04253-6. Epub 2019 May 7.

PMID:
31065850
4.

Lassa virus diversity and feasibility for universal prophylactic vaccine.

Lukashevich IS, Paessler S, de la Torre JC.

F1000Res. 2019 Jan 31;8. pii: F1000 Faculty Rev-134. doi: 10.12688/f1000research.16989.1. eCollection 2019. Review.

5.

Taxonomy of the order Bunyavirales: second update 2018.

Maes P, Adkins S, Alkhovsky SV, Avšič-Županc T, Ballinger MJ, Bente DA, Beer M, Bergeron É, Blair CD, Briese T, Buchmeier MJ, Burt FJ, Calisher CH, Charrel RN, Choi IR, Clegg JCS, de la Torre JC, de Lamballerie X, DeRisi JL, Digiaro M, Drebot M, Ebihara H, Elbeaino T, Ergünay K, Fulhorst CF, Garrison AR, Gāo GF, Gonzalez JJ, Groschup MH, Günther S, Haenni AL, Hall RA, Hewson R, Hughes HR, Jain RK, Jonson MG, Junglen S, Klempa B, Klingström J, Kormelink R, Lambert AJ, Langevin SA, Lukashevich IS, Marklewitz M, Martelli GP, Mielke-Ehret N, Mirazimi A, Mühlbach HP, Naidu R, Nunes MRT, Palacios G, Papa A, Pawęska JT, Peters CJ, Plyusnin A, Radoshitzky SR, Resende RO, Romanowski V, Sall AA, Salvato MS, Sasaya T, Schmaljohn C, Shí X, Shirako Y, Simmonds P, Sironi M, Song JW, Spengler JR, Stenglein MD, Tesh RB, Turina M, Wèi T, Whitfield AE, Yeh SD, Zerbini FM, Zhang YZ, Zhou X, Kuhn JH.

Arch Virol. 2019 Mar;164(3):927-941. doi: 10.1007/s00705-018-04127-3.

PMID:
30663021
6.

Attenuated Replication of Lassa Virus Vaccine Candidate ML29 in STAT-1-/- Mice.

Johnson DM, Jokinen JD, Lukashevich IS.

Pathogens. 2019 Jan 15;8(1). pii: E9. doi: 10.3390/pathogens8010009.

7.

[Oral fluid indicators dynamics in pregnant women by topical calcium-phosphate-fluoride gel application].

Lukashevich IK, Gorbunova IL.

Stomatologiia (Mosk). 2018;97(3):19-22. doi: 10.17116/stomat201897319. Russian.

PMID:
29992934
8.

[Age related molecular-genetic preconditions for dental caries in pregnant women].

Gorbunova IL, Kravchenko EN, Krivchik GV, Shestovskikh OL, Lukashevich IK, Strometskaya NN, Abramyan IR.

Stomatologiia (Mosk). 2018;97(2):27-31. doi: 10.17116/stomat201897227-31. Russian.

PMID:
29795101
9.

Taxonomy of the family Arenaviridae and the order Bunyavirales: update 2018.

Maes P, Alkhovsky SV, Bào Y, Beer M, Birkhead M, Briese T, Buchmeier MJ, Calisher CH, Charrel RN, Choi IR, Clegg CS, de la Torre JC, Delwart E, DeRisi JL, Di Bello PL, Di Serio F, Digiaro M, Dolja VV, Drosten C, Druciarek TZ, Du J, Ebihara H, Elbeaino T, Gergerich RC, Gillis AN, Gonzalez JJ, Haenni AL, Hepojoki J, Hetzel U, Hồ T, Hóng N, Jain RK, Jansen van Vuren P, Jin Q, Jonson MG, Junglen S, Keller KE, Kemp A, Kipar A, Kondov NO, Koonin EV, Kormelink R, Korzyukov Y, Krupovic M, Lambert AJ, Laney AG, LeBreton M, Lukashevich IS, Marklewitz M, Markotter W, Martelli GP, Martin RR, Mielke-Ehret N, Mühlbach HP, Navarro B, Ng TFF, Nunes MRT, Palacios G, Pawęska JT, Peters CJ, Plyusnin A, Radoshitzky SR, Romanowski V, Salmenperä P, Salvato MS, Sanfaçon H, Sasaya T, Schmaljohn C, Schneider BS, Shirako Y, Siddell S, Sironen TA, Stenglein MD, Storm N, Sudini H, Tesh RB, Tzanetakis IE, Uppala M, Vapalahti O, Vasilakis N, Walker PJ, Wáng G, Wáng L, Wáng Y, Wèi T, Wiley MR, Wolf YI, Wolfe ND, Wú Z, Xú W, Yang L, Yāng Z, Yeh SD, Zhāng YZ, Zhèng Y, Zhou X, Zhū C, Zirkel F, Kuhn JH.

Arch Virol. 2018 Aug;163(8):2295-2310. doi: 10.1007/s00705-018-3843-5. Epub 2018 Apr 21.

PMID:
29680923
10.

Mammarenaviral Infection Is Dependent on Directional Exposure to and Release from Polarized Intestinal Epithelia.

Warner NL, Jokinen JD, Beier JI, Sokoloski KJ, Lukashevich IS.

Viruses. 2018 Feb 10;10(2). pii: E75. doi: 10.3390/v10020075.

11.

[Primary progressive multiple sclerosis: current issues of timely diagnosis].

Popova EV, Boyko AN, Barabanova MA, Antipova LN, Bakhtiyarova KZ, Belova AN, Solovieva VS, Belskaya GN, Lukashevich IG, Nikolaeva LI, Volkova LI, Turova EL, Kraeva AV, Goncharova ZA, Malkova NA, Poverennova IE, Sivertseva SA, Zhelnin AV, Trushnikova TN, Khabirov FA, Khaibullin TI.

Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10. Vyp. 2):35-40. doi: 10.17116/jnevro201711710235-40. Review. Russian.

PMID:
29359731
12.

Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.

Wang M, Jokinen J, Tretyakova I, Pushko P, Lukashevich IS.

Vaccine. 2018 Jan 29;36(5):683-690. doi: 10.1016/j.vaccine.2017.12.046. Epub 2017 Dec 26.

13.

A Primate Model for Viral Hemorrhagic Fever.

Salvato MS, Lukashevich IS, Yang Y, Medina-Moreno S, Djavani M, Bryant J, Rodas JD, Zapata JC.

Methods Mol Biol. 2018;1604:279-290. doi: 10.1007/978-1-4939-6981-4_22. Review.

PMID:
28986843
14.

Diagnostics for Lassa Fever: Detecting Host Antibody Responses.

Salvato MS, Lukashevich IS, Medina-Moreno S, Zapata JC.

Methods Mol Biol. 2018;1604:79-88. doi: 10.1007/978-1-4939-6981-4_5.

PMID:
28986826
15.

INFLUENCE OF BETA-BLOCKERS AND IVABRADINE ON LONG-TERM PROGNOSIS OF PATIENTS WITH STABLE ANGINA.

Ilashchuk T, Glubochenko O, Senyuk B, Bachuk-Ponich N, Lukashevich I.

Georgian Med News. 2017 Jun;(267):57-61.

PMID:
28726655
16.

[A role of genetic factors and related disorder of the folate cycle in ischemic stroke].

Shklovsky VM, Lukashevich IP, Remennik AY, Gerasimova SM, Selishchev GS, Malin DI, Valyeva VV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2016;116(8 Pt 2):30-32. doi: 10.17116/jnevro20161168230-32. Russian.

PMID:
27905385
17.

Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials.

Postler TS, Clawson AN, Amarasinghe GK, Basler CF, Bavari S, Benko M, Blasdell KR, Briese T, Buchmeier MJ, Bukreyev A, Calisher CH, Chandran K, Charrel R, Clegg CS, Collins PL, Juan Carlos T, Derisi JL, Dietzgen RG, Dolnik O, Dürrwald R, Dye JM, Easton AJ, Emonet S, Formenty P, Fouchier RAM, Ghedin E, Gonzalez JP, Harrach B, Hewson R, Horie M, Jiang D, Kobinger G, Kondo H, Kropinski AM, Krupovic M, Kurath G, Lamb RA, Leroy EM, Lukashevich IS, Maisner A, Mushegian AR, Netesov SV, Nowotny N, Patterson JL, Payne SL, PaWeska JT, Peters CJ, Radoshitzky SR, Rima BK, Romanowski V, Rubbenstroth D, Sabanadzovic S, Sanfaçon H, Salvato MS, Schwemmle M, Smither SJ, Stenglein MD, Stone DM, Takada A, Tesh RB, Tomonaga K, Tordo N, Towner JS, Vasilakis N, Volchkov VE, Wahl-Jensen V, Walker PJ, Wang LF, Varsani A, Whitfield AE, Zerbini FM, Kuhn JH.

Syst Biol. 2017 May 1;66(3):463-473. doi: 10.1093/sysbio/syw096.

18.

Vaccine platforms to control Lassa fever.

Lukashevich IS, Pushko P.

Expert Rev Vaccines. 2016 Sep;15(9):1135-50. doi: 10.1080/14760584.2016.1184575. Epub 2016 May 24. Review.

PMID:
27136941
19.

DNA-launched live-attenuated vaccines for biodefense applications.

Pushko P, Lukashevich IS, Weaver SC, Tretyakova I.

Expert Rev Vaccines. 2016 Sep;15(9):1223-34. doi: 10.1080/14760584.2016.1175943. Epub 2016 Apr 25. Review.

20.

[Prognostic criteria of rehabilitation of patients with ischemic stroke].

Shklovsky VM, Lukashevich IP, Gerasimova SM, Selishchev GS, Remennik AY.

Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(5):11-14. doi: 10.17116/jnevro20151155111-14. Russian.

PMID:
26356154
21.

[Optimization of postoperative period in patients after colon resection].

Shelygin YA, Achkasov SI, Lukashevich IV.

Khirurgiia (Mosk). 2015;(4):76-81. doi: 10.17116/hirurgia2015476-81. Review. Russian. No abstract available.

PMID:
26103648
22.

Past, present, and future of arenavirus taxonomy.

Radoshitzky SR, Bào Y, Buchmeier MJ, Charrel RN, Clawson AN, Clegg CS, DeRisi JL, Emonet S, Gonzalez JP, Kuhn JH, Lukashevich IS, Peters CJ, Romanowski V, Salvato MS, Stenglein MD, de la Torre JC.

Arch Virol. 2015 Jul;160(7):1851-74. doi: 10.1007/s00705-015-2418-y.

PMID:
25935216
23.

Novel mechanism of arenavirus-induced liver pathology.

Beier JI, Jokinen JD, Holz GE, Whang PS, Martin AM, Warner NL, Arteel GE, Lukashevich IS.

PLoS One. 2015 Mar 30;10(3):e0122839. doi: 10.1371/journal.pone.0122839. eCollection 2015.

24.

[Efficacy of the combination drug vasobral in chronic vascular encephalopathy].

Levin OS, Barantsevich ER, Belskaya GN, Vasenina EE, Kopishinskaya SV, Lukashevich IG, Ostroumova OD, Psokhina OV, Radiuk MA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2014;114(10):25-9. Russian.

PMID:
25591512
25.

Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.

Jiang X, Dalebout TJ, Lukashevich IS, Bredenbeek PJ, Franco D.

J Gen Virol. 2015 Apr;96(Pt 4):804-14. doi: 10.1099/jgv.0.000026. Epub 2014 Dec 16.

26.

Plasmid DNA initiates replication of yellow fever vaccine in vitro and elicits virus-specific immune response in mice.

Tretyakova I, Nickols B, Hidajat R, Jokinen J, Lukashevich IS, Pushko P.

Virology. 2014 Nov;468-470:28-35. doi: 10.1016/j.virol.2014.07.050. Epub 2014 Aug 16.

27.

Genetic variation in vitro and in vivo of an attenuated Lassa vaccine candidate.

Zapata JC, Goicochea M, Nadai Y, Eyzaguirre LM, Carr JK, Tallon LJ, Sadzewicz L, Myers G, Fraser CM, Su Q, Djavani M, Lukashevich IS, Salvato MS.

J Virol. 2014 Mar;88(6):3058-66. doi: 10.1128/JVI.03035-13. Epub 2013 Dec 11.

28.

Transcriptome analysis of human peripheral blood mononuclear cells exposed to Lassa virus and to the attenuated Mopeia/Lassa reassortant 29 (ML29), a vaccine candidate.

Zapata JC, Carrion R Jr, Patterson JL, Crasta O, Zhang Y, Mani S, Jett M, Poonia B, Djavani M, White DM, Lukashevich IS, Salvato MS.

PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2406. doi: 10.1371/journal.pntd.0002406. eCollection 2013.

29.

Vaccine Platforms to Control Arenaviral Hemorrhagic Fevers.

Carrion R Jr, Bredenbeek P, Jiang X, Tretyakova I, Pushko P, Lukashevich IS.

J Vaccines Vaccin. 2012 Nov 20;3(7). pii: 1000160.

30.

An attenuated Lassa vaccine in SIV-infected rhesus macaques does not persist or cause arenavirus disease but does elicit Lassa virus-specific immunity.

Zapata JC, Poonia B, Bryant J, Davis H, Ateh E, George L, Crasta O, Zhang Y, Slezak T, Jaing C, Pauza CD, Goicochea M, Moshkoff D, Lukashevich IS, Salvato MS.

Virol J. 2013 Feb 12;10:52. doi: 10.1186/1743-422X-10-52.

31.

Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a live attenuated vaccine.

Tretyakova I, Lukashevich IS, Glass P, Wang E, Weaver S, Pushko P.

Vaccine. 2013 Feb 4;31(7):1019-25. doi: 10.1016/j.vaccine.2012.12.050. Epub 2012 Dec 31.

32.

The search for animal models for Lassa fever vaccine development.

Lukashevich IS.

Expert Rev Vaccines. 2013 Jan;12(1):71-86. doi: 10.1586/erv.12.139. Review.

33.

[The use of ipidacrinum (neuromidin) in mononeuropathies].

Bel'skaia GN, Popov DV, Gusev VV, Tikhomirova IN, Lukashevich IG, L'vova OA.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(10):31-2. Russian. No abstract available.

PMID:
23250595
34.

Advanced vaccine candidates for Lassa fever.

Lukashevich IS.

Viruses. 2012 Oct 29;4(11):2514-57. doi: 10.3390/v4112514. Review.

35.

Pathogenic Old World arenaviruses inhibit TLR2/Mal-dependent proinflammatory cytokines in vitro.

Hayes MW, Carrion R Jr, Nunneley J, Medvedev AE, Salvato MS, Lukashevich IS.

J Virol. 2012 Jul;86(13):7216-26. doi: 10.1128/JVI.06508-11. Epub 2012 Apr 24.

36.

Evaluation of Lassa virus vaccine immunogenicity in a CBA/J-ML29 mouse model.

Goicochea MA, Zapata JC, Bryant J, Davis H, Salvato MS, Lukashevich IS.

Vaccine. 2012 Feb 14;30(8):1445-52. doi: 10.1016/j.vaccine.2011.12.134. Epub 2012 Jan 9.

37.

[The role of risk subcortical brain regions in the formation alalie].

Lukashevich IP, Popova SM, Shklovskiĭ VM.

Fiziol Cheloveka. 2011 Sep-Oct;37(5):41-5. Russian.

PMID:
22117456
38.

Lymphocytic choriomeningitis virus (LCMV) infection of macaques: a model for Lassa fever.

Zapata JC, Pauza CD, Djavani MM, Rodas JD, Moshkoff D, Bryant J, Ateh E, Garcia C, Lukashevich IS, Salvato MS.

Antiviral Res. 2011 Nov;92(2):125-38. doi: 10.1016/j.antiviral.2011.07.015. Epub 2011 Jul 27. Review.

39.

Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs.

Jiang X, Dalebout TJ, Bredenbeek PJ, Carrion R Jr, Brasky K, Patterson J, Goicochea M, Bryant J, Salvato MS, Lukashevich IS.

Vaccine. 2011 Feb 1;29(6):1248-57. doi: 10.1016/j.vaccine.2010.11.079. Epub 2010 Dec 8.

40.

A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles.

Shtanko O, Imai M, Goto H, Lukashevich IS, Neumann G, Watanabe T, Kawaoka Y.

J Virol. 2010 May;84(10):5415-22. doi: 10.1128/JVI.02417-09. Epub 2010 Mar 3.

41.

Circulating natural killer and gammadelta T cells decrease soon after infection of rhesus macaques with lymphocytic choriomeningitis virus.

Rodas JD, Cairo C, Djavani M, Zapata JC, Ruckwardt T, Bryant J, Pauza CD, Lukashevich IS, Salvato MS.

Mem Inst Oswaldo Cruz. 2009 Jul;104(4):583-91.

42.

Safety, immunogenicity, and efficacy of the ML29 reassortant vaccine for Lassa fever in small non-human primates.

Lukashevich IS, Carrion R Jr, Salvato MS, Mansfield K, Brasky K, Zapata J, Cairo C, Goicochea M, Hoosien GE, Ticer A, Bryant J, Davis H, Hammamieh R, Mayda M, Jett M, Patterson J.

Vaccine. 2008 Sep 26;26(41):5246-54. doi: 10.1016/j.vaccine.2008.07.057. Epub 2008 Aug 8.

43.

[Complex treatment of epilepsy with phenotropil].

Bel'skaia GN, Ponomareva IV, Lukashevich IG, Tikhomirova IN.

Zh Nevrol Psikhiatr Im S S Korsakova. 2007;107(8):40-3. Russian.

PMID:
18379471
44.

Ebola virus matrix protein VP40 uses the COPII transport system for its intracellular transport.

Yamayoshi S, Noda T, Ebihara H, Goto H, Morikawa Y, Lukashevich IS, Neumann G, Feldmann H, Kawaoka Y.

Cell Host Microbe. 2008 Mar 13;3(3):168-77. doi: 10.1016/j.chom.2008.02.001.

45.

Early blood profiles of virus infection in a monkey model for Lassa fever.

Djavani MM, Crasta OR, Zapata JC, Fei Z, Folkerts O, Sobral B, Swindells M, Bryant J, Davis H, Pauza CD, Lukashevich IS, Hammamieh R, Jett M, Salvato MS.

J Virol. 2007 Aug;81(15):7960-73. Epub 2007 May 23.

46.

Lassa virus infection in experimentally infected marmosets: liver pathology and immunophenotypic alterations in target tissues.

Carrion R Jr, Brasky K, Mansfield K, Johnson C, Gonzales M, Ticer A, Lukashevich I, Tardif S, Patterson J.

J Virol. 2007 Jun;81(12):6482-90. Epub 2007 Apr 4.

47.

A ML29 reassortant virus protects guinea pigs against a distantly related Nigerian strain of Lassa virus and can provide sterilizing immunity.

Carrion R Jr, Patterson JL, Johnson C, Gonzales M, Moreira CR, Ticer A, Brasky K, Hubbard GB, Moshkoff D, Zapata J, Salvato MS, Lukashevich IS.

Vaccine. 2007 May 16;25(20):4093-102. Epub 2007 Feb 27.

48.

Molecular characterization of a reassortant virus derived from Lassa and Mopeia viruses.

Moshkoff DA, Salvato MS, Lukashevich IS.

Virus Genes. 2007 Apr;34(2):169-76. Epub 2006 Dec 2.

49.

A recombinant Yellow Fever 17D vaccine expressing Lassa virus glycoproteins.

Bredenbeek PJ, Molenkamp R, Spaan WJ, Deubel V, Marianneau P, Salvato MS, Moshkoff D, Zapata J, Tikhonov I, Patterson J, Carrion R, Ticer A, Brasky K, Lukashevich IS.

Virology. 2006 Feb 20;345(2):299-304. Epub 2006 Jan 18.

50.

[Parameters of EEG in children of early preschool age with consequences of perinatal lesions of the CNS].

Ziborova EV, Lukashevich IP, Shklovskiĭ VM.

Fiziol Cheloveka. 2005 Nov-Dec;31(6):120-2. Russian. No abstract available.

PMID:
16366162

Supplemental Content

Loading ...
Support Center